Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis (Q28740412)

Stephan Schleder

5

0 references

Gerhard Rogler

11

Gerhard Rogler

0 references

Stefan Schreiber

10

Stefan Schreiber

0 references

Andre Franke

3

Andre Franke

0 references

author name string

Florian Rieder

1

0 references

Rocio Lopez

2

0 references

Alexandra Wolf

4

0 references

Andrea Dirmeier

6

0 references

Anja Schirbel

7

0 references

Nir Dotan

9

0 references

Frank Klebl

Creative Commons Attribution 4.0 International

12

0 references

language of work or name

English

0 references

publication date

6 May 2011

0 references

published in

PLOS One

0 references

volume

6

0 references

issue

5

0 references

page(s)

e18172

0 references

copyright license

start time

6 May 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Novel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and Phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

New serological markers in inflammatory bowel disease are associated with complicated disease behaviour

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

Serum anti-glycan antibodies predict complicated Crohn's disease behavior: a cohort study

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

Increased immune reactivity predicts aggressive complicating Crohn's disease in children

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

Anti-glycan antibodies as biomarkers for diagnosis and prognosis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

Utility of serum antibodies in determining clinical course in pediatric Crohn's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

Epidemiology and the natural course of inflammatory bowel disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

The utility of ANCA and ASCA in inflammatory bowel disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior

3 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018172

Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018172

Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018172

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018172

Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089599

Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease

27 November 2018

1 reference

12 December 2020

Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease

1 reference

12 December 2020

Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases

1 reference

12 December 2020

Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype

1 reference

12 December 2020

Decreased anti-Saccharomyces cerevisiae antibody titer by mesalazine in patients with Crohn's disease

1 reference

12 December 2020

Determination of serologic and genetic markers aid in the determination of the clinical course and severity of patients with IBD

1 reference

12 December 2020

Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease

1 reference

12 December 2020